These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10898696)

  • 1. Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.
    Cottagnoud P; Acosta F; Cottagnoud M; Neftel K; Täuber MG
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2179-81. PubMed ID: 10898696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trovafloxacin in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model.
    Rodoni D; Hänni F; Gerber CM; Cottagnoud M; Neftel K; Täuber MG; Cottagnoud P
    Antimicrob Agents Chemother; 1999 Apr; 43(4):963-5. PubMed ID: 10103211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae.
    Kim YS; Liu Q; Chow LL; Täuber MG
    Antimicrob Agents Chemother; 1997 May; 41(5):1186-9. PubMed ID: 9145898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefepime is efficacious against penicillin- and quinolone-resistant pneumococci in experimental meningitis.
    Cottagnoud P; Acosta F; Cottagnoud M; Täuber MG
    J Antimicrob Chemother; 2002 Feb; 49(2):327-30. PubMed ID: 11815575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacies of BMS 284756 against penicillin-sensitive, penicillin-resistant, and quinolone-resistant pneumococci in experimental meningitis.
    Cottagnoud P; Acosta F; Cottagnoud M; Pfister M; Täuber MG
    Antimicrob Agents Chemother; 2002 Jan; 46(1):184-7. PubMed ID: 11751131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemifloxacin is efficacious against penicillin-resistant and quinolone-resistant pneumococci in experimental meningitis.
    Cottagnoud P; Acosta F; Cottagnoud M; Täuber MG
    Antimicrob Agents Chemother; 2002 May; 46(5):1607-9. PubMed ID: 11959614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meropenem alone and in combination with vancomycin in experimental meningitis caused by a penicillin-resistant pneumococcal strain.
    Gerber CM; Cottagnoud M; Neftel KA; Täuber MG; Cottagnoud P
    Eur J Clin Microbiol Infect Dis; 1999 Dec; 18(12):866-70. PubMed ID: 10691197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci.
    Flatz L; Cottagnoud M; Kühn F; Entenza J; Stucki A; Cottagnoud P
    J Antimicrob Chemother; 2004 Feb; 53(2):305-10. PubMed ID: 14729741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of gatifloxacin alone and in combination with cefepime against penicillin-resistant Streptococcus pneumoniae in a rabbit meningitis model and in vitro.
    Perrig M; Acosta F; Cottagnoud M; Gerber CM; Täuber MG; Cottagnoud P
    J Antimicrob Chemother; 2001 May; 47(5):701-4. PubMed ID: 11328789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of treatment with penicillin, ceftriaxone, trovafloxacin, quinupristin-dalfopristin and vancomycin in experimental endocarditis due to penicillin- and ceftriaxone-resistant Streptococcus pneumoniae.
    López Fornas F; Martínez García F; Pérez Salmeron J; Roldán Conesa D; Cortés Sanchez R; García Alberola A; Ruíz Gómez J; Gómez Gómez J; Valdés Chávarri M
    J Antimicrob Chemother; 2001 May; 47(5):623-9. PubMed ID: 11328774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grepafloxacin against penicillin-resistant pneumococci in the rabbit meningitis model.
    Gerber CM; Tovar L; Cottagnoud M; Neftel KA; Täuber MG; Cottagnoud P
    J Antimicrob Chemother; 2000 Aug; 46(2):249-53. PubMed ID: 10933648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro and in-vivo activity of trovafloxacin against Streptococcus pneumoniae.
    Klugman KP; Gootz TD
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():51-5. PubMed ID: 9222070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trovafloxacin delays the antibiotic-induced inflammatory response in experimental pneumococcal meningitis.
    Nau R; Zysk G; Schmidt H; Fischer FR; Stringaris AK; Stuertz K; Brück W
    J Antimicrob Chemother; 1997 Jun; 39(6):781-8. PubMed ID: 9222048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemifloxacin is effective in experimental pneumococcal meningitis.
    Smirnov A; Wellmer A; Gerber J; Maier K; Henne S; Nau R
    Antimicrob Agents Chemother; 2000 Mar; 44(3):767-70. PubMed ID: 10681354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
    París MM; Hickey SM; Trujillo M; Shelton S; McCracken GH
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1243-6. PubMed ID: 7574509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefotaxime acts synergistically with levofloxacin in experimental meningitis due to penicillin-resistant pneumococci and prevents selection of levofloxacin-resistant mutants in vitro.
    Kühn F; Cottagnoud M; Acosta F; Flatz L; Entenza J; Cottagnoud P
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2487-91. PubMed ID: 12878509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic activity of trovafloxacin and ceftriaxone or vancomycin against Streptococcus pneumoniae with various penicillin susceptibilities.
    Nicolau DP; Tessier PR; Quintiliani R; Nightingale CH
    Antimicrob Agents Chemother; 1998 Apr; 42(4):991-2. PubMed ID: 9559832
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of cefepime alone and in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.
    Gerber CM; Cottagnoud M; Neftel K; Täuber MG; Cottagnoud P
    J Antimicrob Chemother; 2000 Jan; 45(1):63-8. PubMed ID: 10629014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
    Friedland IR; Paris M; Ehrett S; Hickey S; Olsen K; McCracken GH
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1630-6. PubMed ID: 8215275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moxifloxacin in the therapy of experimental pneumococcal meningitis.
    Schmidt H; Dalhoff A; Stuertz K; Trostdorf F; Chen V; Schneider O; Kohlsdorfer C; Brück W; Nau R
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1397-407. PubMed ID: 9624483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.